Claude B. Sirlin

Claude B. Sirlin's AcademicInfluence.com Rankings

Claude B. Sirlin

Physics

#3834

World Rank

#5372

Historical Rank

physics Degrees

Download Badge

Physics

Claude B. Sirlin's Degrees

PhD Physics Stanford University

Why Is Claude B. Sirlin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Claude B. Sirlin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

AASLD guidelines for the treatment of hepatocellular carcinoma (2018) (2569)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases (2018) (2291)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases (2019) (1451)
Ru-, Rh-, and Pd-catalyzed C-C bond formation involving C-H activation and addition on unsaturated substrates: reactions and mechanistic aspects. (2002) (1414)
Decoding global gene expression programs in liver cancer by noninvasive imaging (2007) (522)
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy (2011) (517)
Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. (2018) (498)
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. (2017) (487)
In vivo characterization of the liver fat 1H MR spectrum (2011) (458)
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials (2013) (404)
LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions (2015) (388)
Relaxation effects in the quantification of fat using gradient echo imaging. (2008) (387)
Fatty liver: imaging patterns and pitfalls. (2013) (386)
Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. (2013) (383)
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. (2014) (374)
Nonalcoholic fatty liver disease (2015) (374)
Proton density fat‐fraction: A standardized mr‐based biomarker of tissue fat concentration (2012) (372)
Magnetic Resonance Elastography Predicts Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Study (2014) (371)
SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. (2010) (366)
Heritability of nonalcoholic fatty liver disease. (2009) (362)
Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. (2011) (355)
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. (2014) (352)
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis (2017) (320)
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease. (2017) (305)
Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. (2010) (304)
Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. (2009) (300)
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non‐alcoholic fatty liver disease – MRI accurately quantifies hepatic steatosis in NAFLD (2012) (291)
Ezetimibe for the Treatment of Nonalcoholic Steatohepatitis: Assessment by Novel Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Randomized Trial (MOZART Trial) (2015) (277)
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis (2018) (275)
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. (2016) (268)
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. (2011) (261)
Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. (2009) (258)
Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study. (2015) (255)
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial. (2016) (252)
Pediatric Nonalcoholic Fatty Liver Disease: A Critical Appraisal of Current Data and Implications for Future Research (2006) (251)
Quantification of liver fat with magnetic resonance imaging. (2010) (248)
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. (2019) (242)
CT evaluation of appendicitis and its complications: imaging techniques and key diagnostic findings. (2005) (235)
A Computed Tomography Radiogenomic Biomarker Predicts Microvascular Invasion and Clinical Outcomes in Hepatocellular Carcinoma (2015) (234)
Noninvasive, Quantitative Assessment of Liver Fat by MRI‐PDFF as an Endpoint in NASH Trials (2018) (232)
cHCC‐CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation (2018) (229)
MR imaging of liver fibrosis: current state of the art. (2009) (223)
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. (2019) (222)
Effect of Colesevelam on Liver Fat Quantified by Magnetic Resonance in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial (2012) (220)
Abdominal wall hernias: imaging features, complications, and diagnostic pitfalls at multi-detector row CT. (2005) (219)
Quantification of liver iron with MRI: State of the art and remaining challenges (2014) (217)
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review. (2018) (209)
Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification (2009) (208)
Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants (2019) (206)
Gene transfer with a series of lipophilic DNA-binding molecules. (1994) (201)
CT and MR imaging of extrahepatic fatty masses of the abdomen and pelvis: techniques, diagnosis, differential diagnosis, and pitfalls. (2005) (201)
How to perform Contrast-Enhanced Ultrasound (CEUS) (2018) (200)
Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. (2006) (199)
T1 independent, T2* corrected chemical shift based fat–water separation with multi‐peak fat spectral modeling is an accurate and precise measure of hepatic steatosis (2011) (198)
Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. (2010) (196)
Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis (2018) (196)
Disproportionate fat stranding: a helpful CT sign in patients with acute abdominal pain. (2004) (195)
Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. (2015) (193)
Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique. (2015) (187)
Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis (2016) (186)
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease (2019) (186)
Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review. (2019) (184)
Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis. (2017) (183)
Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. (2011) (183)
Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions. (2018) (178)
Combination of complex‐based and magnitude‐based multiecho water‐fat separation for accurate quantification of fat‐fraction (2011) (177)
2017 Version of LI-RADS for CT and MR Imaging: An Update. (2017) (175)
A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene CHOP. (2009) (175)
Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis. (2017) (172)
Magnetic resonance imaging quantification of liver iron. (2010) (172)
Magnetic resonance elastography vs. transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease (2017) (168)
Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. (2008) (166)
Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy‐proven nonalcoholic fatty liver disease: A prospective study (2016) (160)
Whole-body CT screening: spectrum of findings and recommendations in 1192 patients. (2005) (160)
Mesomorphic molecular materials for electronics, opto-electronics, iono-electronics: Octaalkyl-phthalocyanine derivatives (1989) (160)
Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma (2015) (159)
Blunt abdominal trauma: screening us in 2,693 patients. (2001) (156)
Non‐invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE (2016) (156)
Liver Imaging Reporting and Data System (2020) (155)
Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study. (2008) (154)
MR contrast agents for liver imaging: what, when, how. (2006) (152)
Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study (2016) (150)
Review article: epidemiology, pathogenesis and potential treatments of paediatric non‐alcoholic fatty liver disease (2008) (149)
Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation. (1997) (147)
Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 2, Diagnostic Performance, Confounders, and Future Directions. (2015) (146)
Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma. (2007) (144)
Current status of imaging in nonalcoholic fatty liver disease (2018) (141)
Advances in pediatric nonalcoholic fatty liver disease (2009) (141)
Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 1, Principles and Techniques. (2015) (137)
Acetyl‐CoA Carboxylase Inhibitor GS‐0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis (2018) (135)
Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease (2015) (134)
Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial (2019) (134)
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. (2020) (132)
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib. (2019) (132)
Microbiome Signatures Associated with Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease. (2019) (132)
Reproducibility of MRI‐determined proton density fat fraction across two different MR scanner platforms (2011) (130)
Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging. (2018) (130)
Noninvasive assessment of hepatic steatosis. (2009) (128)
Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist (2012) (128)
ISMRM workshop on fat–water separation: Insights, applications and progress in MRI (2012) (128)
CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI (2017) (125)
Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective study (2015) (124)
Electrical and magnetic properties of liquid crystalline molecular materials lithium and lutetium phthalocyanine derivatives (1989) (121)
Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis. (2015) (118)
Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. (2011) (118)
Ruthenium (II)-Derived Organometallic Compounds Induce Cytostatic and Cytotoxic Effects on Mammalian Cancer Cell Lines through p53-Dependent and p53-Independent Mechanisms (2005) (116)
Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. (2019) (114)
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis (2017) (114)
Link between gut‐microbiome derived metabolite and shared gene‐effects with hepatic steatosis and fibrosis in NAFLD (2018) (114)
An Effective Route to Cycloruthenated N-Ligands under Mild Conditions (1999) (110)
Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid (2016) (110)
Influence of the nature of the side chains on the mesomorphic properties of octasubstituted phthalocyanine derivatives. Annelides XXIX (1988) (109)
Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis (2016) (108)
Evidence and recommendations for imaging liver fat in children, based on systematic review. (2014) (108)
Association between novel MRI‐estimated pancreatic fat and liver histology‐determined steatosis and fibrosis in non‐alcoholic fatty liver disease (2013) (108)
Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity. (2019) (106)
Hypotensive patients with blunt abdominal trauma: performance of screening US. (2005) (104)
Imaging features of perivascular fatty infiltration of the liver: initial observations. (2005) (103)
Hepatic Fat Quantification: A Prospective Comparison of Magnetic Resonance Spectroscopy and Analysis Methods for Chemical-Shift Gradient Echo Magnetic Resonance Imaging With Histologic Assessment as the Reference Standard (2012) (103)
Hepatobiliary agents and their role in LI-RADS (2015) (102)
Shell osteochondral allografts of the knee: comparison of mr imaging findings and immunologic responses. (2001) (100)
Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease (2018) (99)
Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS®): the official version by the American College of Radiology (ACR) (2017) (98)
Cycloruthenated primary and secondary amines as efficient catalyst precursors for asymmetric transfer hydrogenation. (2005) (96)
Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies. (2007) (95)
Ion channel containing mesophases: structural characteristics of condensed phases of crown-ether-substituted phthalocyanines (1987) (93)
Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease (2017) (93)
Carotid arteries: contrast-enhanced US angiography--preliminary clinical experience. (2004) (93)
Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. (2015) (92)
Multisite, multivendor validation of the accuracy and reproducibility of proton‐density fat‐fraction quantification at 1.5T and 3T using a fat–water phantom (2017) (92)
CT appearance of the normal appendix in adults (2005) (91)
Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency. (2014) (90)
Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system (2017) (90)
Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis. (2015) (89)
American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for the diagnosis of Hepatocellular Carcinoma: a pictorial essay (2017) (88)
Optimal phased-array combination for spectroscopy. (2008) (87)
Abdominal wall hernias: MDCT findings. (2004) (87)
Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. (2018) (86)
Blunt abdominal trauma: clinical value of negative screening US scans. (2004) (85)
Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging (2015) (83)
Cisterna chyli at routine abdominal MR imaging: a normal anatomic structure in the retrocrural space. (2004) (81)
A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease. (2017) (80)
Imaging Outcomes of Liver Imaging Reporting and Data System Version 2014 Category 2, 3, and 4 Observations Detected at CT and MR Imaging. (2016) (80)
LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance (2019) (78)
Repeatability of MR Elastography of Liver: A Meta-Analysis. (2017) (77)
Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas (2012) (76)
Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study. (2018) (74)
Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: passing the nanomolar barrier. (2011) (73)
Spatial distribution of MRI‐determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease (2014) (72)
Predictors of patient response to pulmonary thromboendarterectomy. (2000) (71)
Automated CT and MRI Liver Segmentation and Biometry Using a Generalized Convolutional Neural Network. (2019) (70)
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging (2013) (70)
LI-RADS Version 2018 Ancillary Features at MRI. (2018) (69)
Cyclometalated Complexes of Ruthenium, Rhodium and Iridium as Catalysts for Transfer Hydrogenation of Ketones and Imines (2011) (68)
Reproducibility of MR‐based liver fat quantification across field strength: Same‐day comparison between 1.5T and 3T in obese subjects (2015) (68)
Synthesis, characterization, and electrochemistry of biorelevant photosensitive low-potential orthometalated ruthenium complexes. (2005) (66)
Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study (2016) (65)
Adaptive local window for level set segmentation of CT and MRI liver lesions (2016) (65)
Cyclometalation of Primary Benzyl Amines by Ruthenium(II), Rhodium(III), and Iridium(III) Complexes (2007) (65)
Change in MRI-PDFF and Histologic Response in Patients with Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. (2020) (64)
Imaging-based diagnostic systems for hepatocellular carcinoma. (2013) (62)
Synthesis of cycloruthenated compounds as potential anticancer agents (2007) (60)
Induction of caspase 8 and reactive oxygen species by ruthenium-derived anticancer compounds with improved water solubility and cytotoxicity. (2012) (57)
Annelides. XXI: Highly ordered columnar liquid crystal obtained from a new octasubstituted phthalocyanine mesogen (1988) (57)
Chest radiography with a flat-panel detector: image quality with dose reduction after copper filtration. (2005) (57)
Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening. (2017) (56)
Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion‐weighted MRI measurements in adults (2015) (56)
Indeterminate observations (liver imaging reporting and data system category 3) on MRI in the cirrhotic liver: fate and clinical implications. (2013) (56)
Acetaminophen Pharmacokinetics in Children With Nonalcoholic Fatty Liver Disease (2011) (56)
Molecular catalysis: enhanced rates of thiolysis with high structural and chiral recognition in complexes of a reactive macrocyclic receptor molecule (1978) (55)
Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast‐enhanced magnetic resonance images (2012) (55)
Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults (2015) (54)
Multicenter Validation of Association Between Decline in MRI‐PDFF and Histologic Response in NASH (2020) (53)
Bone mineral density and atherosclerosis: the Multi-Ethnic Study of Atherosclerosis, Abdominal Aortic Calcium Study. (2010) (52)
Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study. (2005) (50)
White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI (2018) (50)
Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. (2004) (50)
Liver Imaging Reporting and Data System Version 2018: Impact on Categorization and Hepatocellular Carcinoma Staging (2019) (50)
Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks. (2020) (48)
Assessment of liver fat quantification in the presence of iron. (2010) (48)
Understanding LI-RADS: a primer for practical use. (2014) (48)
Importance of evaluating organ parenchyma during screening abdominal ultrasonography after blunt trauma. (2001) (47)
Inter‐examination precision of magnitude‐based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects (2014) (46)
Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ (2017) (46)
Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease (2020) (45)
MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis (2020) (45)
Application of Modified Spin-Echo-based Sequences for Hepatic MR Elastography: Evaluation, Comparison with the Conventional Gradient-Echo Sequence, and Preliminary Clinical Experience. (2017) (44)
Screening Ultrasound in Blunt Abdominal Trauma (2003) (44)
Consensus report of the Fifth International Forum for Liver MRI. (2013) (43)
Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial. (2017) (43)
Accuracy and the effect of possible subject‐based confounders of magnitude‐based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference (2016) (43)
Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data‐based, T1‐independent, T2*‐corrected, spectrum‐modeled MRI (2014) (43)
Us of blunt abdominal trauma: importance of free pelvic fluid in women of reproductive age. (2001) (42)
How bariatric surgery affects liver volume and fat density in NAFLD patients (2018) (42)
Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls (2013) (42)
Screening US for blunt abdominal trauma: objective predictors of false-negative findings and missed injuries. (2003) (42)
Screening Sonography in Pregnant Patients With Blunt Abdominal Trauma (2005) (41)
Consensus report from the 6th International forum for liver MRI using gadoxetic acid (2014) (41)
Pediatric nonalcoholic fatty liver disease: a comprehensive review. (2010) (41)
LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: a pictorial atlas. (2014) (41)
Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis. (2008) (41)
Contrast-enhanced B-mode US angiography in the assessment of experimental in vivo and in vitro atherosclerotic disease. (2001) (40)
DNA binding to an anticancer organo-ruthenium complex. (2010) (40)
Liver Imaging Reporting and Data System: an expert consensus statement (2017) (40)
Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI (2013) (40)
Acute appendicitis: diagnostic value of nonenhanced CT with selective use of contrast in routine clinical settings (2007) (39)
Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis. (2018) (39)
In vivo triglyceride composition of abdominal adipose tissue measured by 1H MRS at 3T (2017) (39)
Silver nitrate refining using supported liquid membranes (1990) (38)
MRI of the female pelvis using vaginal gel. (2005) (38)
Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease (2018) (38)
Constraining the initial phase in water-fat separation. (2011) (38)
Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease? (2019) (38)
Cirrhotic liver: What's that nodule? The LI‐RADS approach (2016) (37)
Kinetics and Mechanism of Ruthenacycle-Catalyzed Asymmetric Hydrogen Transfer (2008) (37)
Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography (2020) (36)
Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease (2017) (36)
Cardiac motion in diffusion‐weighted MRI of the liver: artifact and a method of correction (2012) (36)
Quantification of fluid on screening ultrasonography for blunt abdominal trauma: a simple scoring system to predict severity of injury. (2001) (36)
Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging. (2012) (36)
Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening (2020) (35)
Role of US LI-RADS in the LI-RADS Algorithm. (2019) (35)
Randomised clinical trial: a leucine‐metformin‐sildenafil combination (NS‐0200) vs placebo in patients with non‐alcoholic fatty liver disease (2018) (33)
How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma (2016) (33)
Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid (2019) (33)
Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma. (2019) (32)
LI-RADS® algorithm: CT and MRI (2017) (32)
Quantifying Abdominal Adipose Tissue and Thigh Muscle Volume and Hepatic Proton Density Fat Fraction: Repeatability and Accuracy of an MR Imaging-based, Semiautomated Analysis Method. (2017) (32)
Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US. (2020) (32)
Female pelvis. (2005) (32)
Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study (2018) (31)
LI-RADS categories: concepts, definitions, and criteria (2017) (31)
Unusual cause of ureteral obstruction in transplant kidney (2006) (31)
Accuracy of multiecho magnitude‐based MRI (M‐MRI) for estimation of hepatic proton density fat fraction (PDFF) in children (2015) (30)
Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience. (2019) (30)
Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice. (2020) (30)
Magnetic resonance elastography identifies fibrosis in adults with alpha‐1 antitrypsin deficiency liver disease: a prospective study (2016) (30)
Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease (2018) (30)
MRI Assessment of Treatment Response in HIV‐associated NAFLD: A Randomized Trial of a Stearoyl‐Coenzyme‐A‐Desaturase‐1 Inhibitor (ARRIVE Trial) (2019) (30)
Weight Loss Decreases Magnetic Resonance Elastography Estimated Liver Stiffness in Nonalcoholic Fatty Liver Disease (2017) (30)
Repeatability and Reproducibility of a Clinically Based QUS Phantom Study and Methodologies (2017) (29)
In vivo breath‐hold 1H MRS simultaneous estimation of liver proton density fat fraction, and T1 and T2 of water and fat, with a multi‐TR, multi‐TE sequence (2015) (29)
Abbreviated MRI for Hepatocellular Carcinoma Screening and Surveillance. (2020) (29)
Nephrogenic systemic fibrosis in liver disease: A systematic review (2009) (29)
PdCl2, a useful catalyst for protection of alcohols as diphenylmethyl (DPM) ethers (2007) (28)
Spinal columnar liquid crystals: polymeric octasubstituted µ-oxo-(phthalocyaninato)tin(IV) (1987) (27)
Evaluation of Liver Fibrosis Using Texture Analysis on Combined-Contrast-Enhanced Magnetic Resonance Images at 3.0T (2015) (27)
Recognition of Chiral Carboxylic Anions by Artificial Receptors (2010) (27)
Effect of acquisition rate on liver and portal vein enhancement with microbubble contrast. (1999) (27)
Elastography to assess the stage of liver fibrosis in children: Concepts, opportunities, and challenges (2017) (26)
Optically active ortho-metalated half-sandwich ruthenium complexes: solid-state NMR as a convenient tool to analyze mixtures of diastereomers. (2001) (26)
Diarylmethyl ethers and Pd salts or complexes: a perfect combination for the protection and deprotection of alcohols (2008) (25)
Spinal columnar liquid crystals based on octasubstituted phthalocyanine siloxane derivatives (1988) (25)
Reaction of Chiral Secondary Amines with [(η5-C5Me5)MCl2]2 (M = Rh(III), Ir(III)): Cyclometalation with or without Dehydrogenation (2011) (25)
Liver histology and diffusion‐weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study (2017) (25)
Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review (2019) (25)
Cyclometalation of Secondary Benzyl Amines by Ruthenium(II) Complexes (2007) (25)
Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease (2021) (25)
Cross-sectional and longitudinal evaluation of liver volume and total liver fat burden in adults with nonalcoholic steatohepatitis (2014) (25)
Repeatability and reproducibility of 2D and 3D hepatic MR elastography with rigid and flexible drivers at end-expiration and end-inspiration in healthy volunteers (2017) (24)
Pediatric Hepatoblastoma, Hepatocellular Carcinoma, and Other Hepatic Neoplasms: Consensus Imaging Recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group. (2020) (24)
Prospective, Same-day, Direct Comparison of CAP With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Standard. (2019) (24)
Polycondensation in Mesomorphic Phases: Spinal Columnar Liquid Crystals Based on Octasubstituted Phthalocyanine Siloxane Derivatives (1988) (24)
MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis (2018) (24)
Deep learning assisted differentiation of hepatocellular carcinoma from focal liver lesions: choice of four-phase and three-phase CT imaging protocol (2020) (24)
Assessment of treatment response in non‐alcoholic steatohepatitis using advanced magnetic resonance imaging (2017) (24)
Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium‐based contrast agents (2015) (24)
Inter-sonographer reproducibility of quantitative ultrasound outcomes and shear wave speed measured in the right lobe of the liver in adults with known or suspected non-alcoholic fatty liver disease (2018) (24)
Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease (2018) (23)
Screening and Surveillance of Hepatocellular Carcinoma: An Introduction to Ultrasound Liver Imaging Reporting and Data System. (2017) (23)
Polydioxanone biodegradable pins in the knee: MR imaging. (2001) (23)
Acetyl-CoA carboxylase (ACC) inhibitor GS-0976 leads to suppression of hepatic de novo lipogenesis and significant improvements in MRI-PDFF, MRE, and markers of fibrosis after 12 weeks of therapy in patients with NASH (2017) (23)
Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know (2015) (23)
Fat Quantification in the Abdomen (2017) (23)
Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI‐RADS) (2019) (23)
Technology Insight: advances in liver imaging (2007) (23)
Accurate diagnosis of nonalcoholic fatty liver disease in human participants via quantitative ultrasound (2014) (23)
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. (2020) (23)
Hepatocarcinogenesis and LI-RADS (2017) (23)
Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis (2007) (23)
CT/MR LI-RADS 2018: clinical implications and management recommendations (2018) (23)
Effects of intravenous gadolinium administration and flip angle on the assessment of liver fat signal fraction with opposed‐phase and in‐phase imaging (2008) (23)
Recommendation for terminology: Nodules without arterial phase hyperenhancement and with hepatobiliary phase hypointensity in chronic liver disease (2018) (23)
Automated registration of sequential breath-hold dynamic contrast-enhanced MR images: a comparison of three techniques. (2011) (22)
Pitfalls and problems to be solved in the diagnostic CT/MRI Liver Imaging Reporting and Data System (LI-RADS) (2018) (22)
Robustness of fat quantification using chemical shift imaging. (2012) (22)
Effect of echo‐sampling strategy on the accuracy of out‐of‐phase and in‐phase multiecho gradient‐Echo MRI hepatic fat fraction estimation (2014) (22)
Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease (2021) (22)
Patterns of fluid accumulation on screening ultrasonography for blunt abdominal trauma: comparison with site of injury. (2001) (22)
LI-RADS and transplantation for hepatocellular carcinoma (2017) (21)
Ru‐, Rh‐, and Pd‐Catalyzed C—C Bond Formation Involving C—H Activation and Addition on Unsaturated Substrates: Reactions and Mechanistic Aspects (2002) (21)
Collagen Formation Assessed by N‐Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography (2019) (21)
Transmetalation of Aryl Units from Gold(I) to Cobalt(III): A Clean Route to the Synthesis of Anion Cobaltoreceptors (2005) (20)
Palladium-mediated intramolecular C–N bond formation involving allyl substituted pyridines. Application to a novel strategy for the synthesis of the skeleton of berberinium derivatives (2003) (20)
Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease (2018) (19)
Deep convolutional neural network applied to the liver imaging reporting and data system (LI-RADS) version 2014 category classification: a pilot study (2019) (19)
An update for LI‐RADS: Version 2018. Why so soon after version 2017? (2019) (19)
Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom Study. (2021) (19)
Accuracy of PDFF estimation by magnitude‐based and complex‐based MRI in children with MR spectroscopy as a reference (2017) (19)
Nonstandardized Terminology to Describe Focal Liver Lesions in Patients at Risk for Hepatocellular Carcinoma: Implications Regarding Clinical Communication. (2018) (19)
Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease. (2021) (18)
Normal range for MR elastography measured liver stiffness in children without liver disease (2020) (18)
Cross‐sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis (2018) (18)
Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD (2019) (18)
Evaluation of MRI fat fraction in the liver and spine pre and post SPIO infusion. (2013) (18)
The Role of Preoperative Dynamic Contrast-enhanced 3.0-T MR Imaging in Predicting Early Recurrence in Patients With Early-Stage Hepatocellular Carcinomas After Curative Resection (2019) (18)
Science to practice: Can T1rho imaging be used to diagnose and assess the severity of hepatic fibrosis? (2011) (18)
Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly. (2016) (18)
Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease (2015) (17)
Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study (2022) (17)
Error model for reduction of cardiac and respiratory motion effects in quantitative liver DW‐MRI (2013) (17)
Liver Fat Assessment in Multiview Sonography Using Transfer Learning With Convolutional Neural Networks (2021) (17)
Cycloruthenated compounds as efficient catalyst for asymmetric hydride transfer reaction (2006) (17)
Optimization of region‐of‐interest sampling strategies for hepatic MRI proton density fat fraction quantification (2018) (16)
Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study. (2019) (16)
Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes. (2020) (16)
CT and MRI of diffuse lobar involvement pattern in liver pathology. (2011) (16)
Liver Imaging Reporting and Data System Category 5 (LI-RADS LR-5): MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma. (2019) (16)
Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease. (2017) (16)
CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis. (2021) (16)
Online Liver Imaging Course; Pivoting to Transform Radiology Education During the SARS-CoV-2 Pandemic (2020) (16)
Pathologic, Molecular, and Prognostic Radiologic Features of Hepatocellular Carcinoma. (2021) (16)
Diagnosis of Hepatocellular Carcinoma with Non-Invasive Imaging: a Plea for Worldwide Adoption of Standard and Precise Terminology for Describing Enhancement Criteria (2017) (16)
Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach (2020) (15)
Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection (2020) (15)
Inter- and intra-reader agreement for gadoxetic acid–enhanced MRI parameter readings in patients with chronic liver diseases (2019) (15)
Longitudinal evolution of CT and MRI LI-RADS v2014 category 1, 2, 3, and 4 observations (2019) (15)
Cycloruthenated tertiary amines and ethylene: further insight to the Ru-mediated olefin–aryl coupling reaction (2000) (15)
A Quantitative Approach to Sequence and Image Weighting (2010) (15)
Head to head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD. (2022) (15)
Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis: the FNIH NIMBLE project (2022) (14)
Capsular retraction: an uncommon imaging finding in hepatic inflammatory pseudotumour. (2009) (14)
Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI (2020) (14)
Accuracy of common proton density fat fraction thresholds for magnitude- and complex-based chemical shift-encoded MRI for assessing hepatic steatosis in patients with obesity (2019) (14)
Reaction between ethylene and cycloruthenated tertiary amines: Stoichiometric olefin arylation and stereospecific one-carbon-atom insertion (2003) (14)
Diagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference Standard. (2015) (14)
Spectrum of Pitfalls, Pseudolesions, and Potential Misdiagnoses in Cirrhosis. (2018) (14)
Sources of systematic error in proton density fat fraction (PDFF) quantification in the liver evaluated from magnitude images with different numbers of echoes (2018) (14)
Palladium‐Catalysed Synthesis of Dibenzo[de,g]quinolines. A Novel Approach to the B‐Ring System of Aporphine‐Related Heterocycles (1999) (13)
Electrosynthesis of Octasubstituted (Dihydrogen and Radical Lithium) Phthalocyanines (1992) (13)
User and system pitfalls in liver imaging with LI‐RADS (2019) (13)
A Pilot Genome‐Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASH (2019) (13)
Management implications and outcomes of LI-RADS-2, -3, -4, and -M category observations (2017) (13)
LI-RADS: a glimpse into the future (2017) (12)
Longitudinal comparison between MRI , MRS and histology-determined steatosis in NAFLD patients at two-time points in a randomized trial (2013) (12)
Effect of threshold growth as a major feature on LI-RADS categorization (2017) (12)
Molecular Library Obtained by Allene Insertion into the Pd−C Bond of Cyclopalladated Complexes: Biological and Pharmacological Evaluation (2004) (12)
On confirmation bias in imaging research (2015) (12)
Novel link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD (2018) (12)
LI-RADS ancillary features on contrast-enhanced ultrasonography (2020) (12)
Is It Time to Expand the Definition of Washout Appearance in LI-RADS? (2019) (12)
Apparent diffusion coefficient of fibrosis and regenerative nodules in the cirrhotic liver at MRI. (2010) (12)
LI-RADS version 2018: What is new and what does this mean to my radiology reports? (2018) (12)
Pilot study on longitudinal change in pancreatic proton density fat fraction during a weight‐loss surgery program in adults with obesity (2019) (11)
Structural and optical properties of new cyclometalated Ru(II) derived compounds (2014) (11)
Liver Imaging Reporting and Data System: Review of Ancillary Imaging Features. (2016) (11)
Quantification of the Hemodynamic Changes of Cirrhosis with Free‐Breathing Self‐Navigated MRI (2021) (11)
Screening sonography in pregnant patients with blunt abdominal trauma. (2005) (11)
MRE plus FIB-4 (MEFIB) versus FAST in detection of candidates for pharmacological treatment of NASH-related fibrosis. (2021) (11)
Palladium-assisted intramolecular formation of n-heterocycles by sp2 N nucleophilic attack on η3-allyl-Pd complexes generated by allene insertion into σ PdC bond (1996) (11)
Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial (2016) (11)
Effect of ultrasound transmit power on liver enhancement with Imagent® US, a PFC‐stabilized microbubble contrast agent (1997) (11)
Effect of shot number on the calculated apparent diffusion coefficient in phantoms and in human liver in diffusion‐weighted echo‐planar imaging (2009) (10)
Reader agreement and accuracy of ultrasound features for hepatic steatosis (2018) (10)
Sitagliptin Versus Placebo in the Treatment of Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial (2016) (10)
Time to Clarify Common Misconceptions about the Liver Imaging Reporting and Data System for Contrast-enhanced US. (2020) (10)
Molecular Recognition of Anions by a Novel Organocobalt Receptor: Oxyanion versus Halide Selectivity in Water (2002) (10)
Histogram Analysis of Hepatobiliary Phase MR Imaging as a Quantitative Value for Liver Cirrhosis: Preliminary Observations (2014) (10)
Body MRI artefacts: from image degradation to diagnostic utility (2009) (10)
Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease (2021) (10)
Editorial on the Current Role of Ultrasound (2019) (10)
Amphicrine carcinoma of the liver. (2011) (10)
Noninvasive imaging biomarkers for steatosis assessment (2009) (10)
Imaging diagnosis of hepatocellular carcinoma: LI-RADS. (2020) (10)
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. (2022) (10)
Cirrhosis and LI-RADS (2017) (10)
The LI-RADS adventure—a personal statement (2017) (9)
Enhanced ligation of DNA with a synthetic effector molecule (1993) (9)
B-mode enhancement of the liver with microbubble contrast agent: a blinded study in rabbits with VX2 tumors. (2001) (9)
Liver Imaging Reporting and Data System: Review of Major Imaging Features. (2016) (9)
One-Pot Generation of a Tris-cationic Homobimetallic Planar-Chiral Ruthenacycle (2010) (9)
Liver imaging: it is time to adopt standardized terminology (2022) (8)
Magnetic resonance elastography plus Fibrosis‐4 versus FibroScan–aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH‐related fibrosis (2021) (8)
Optimal Threshold of Controlled Attenuation Parameter for Detection of HIV-Associated NAFLD With Magnetic Resonance Imaging as the Reference Standard. (2020) (8)
Consuming Sucrose- or HFCS-sweetened Beverages Increases Hepatic Lipid and Decreases Insulin Sensitivity in Adults (2021) (8)
Hepatic steatosis and reduction in steatosis following bariatric weight loss surgery differs between segments and lobes (2018) (8)
Spectrally-Modeled Hepatic Fat Quantification by Multi-Echo Gradient-Recalled-Echo Magnetic Resonance Imaging at 3.0T (2009) (8)
Effect of intravenous gadoxetate disodium and flip angle on hepatic proton density fat fraction estimation with six-echo, gradient-recalled-echo, magnitude-based MR imaging at 3T (2017) (8)
Assessment of a high‐SNR chemical‐shift‐encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low‐fat range (2019) (7)
Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models. (2015) (7)
Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging (2021) (7)
CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma. Part II. Extracellular Agents, Hepatobiliary Agents, and (2014) (7)
Epidemiology of Hepatic Steatosis at a Tertiary Care Center: An MRI-based Analysis. (2017) (7)
Dairy Fat Intake, Plasma C15: 0 and Plasma Iso-C17: 0 are Inversely Associated with Liver Fat in Children. (2020) (7)
LI-RADS ancillary feature prediction of longitudinal category changes in LR-3 observations: an exploratory study (2020) (7)
Selective head-to-tail coupling of methyl phenylpropynoate providing palladacycles with bidentate N-ligands (2006) (7)
Longitudinal changes in liver stiffness by magnetic resonance elastography (MRE), liver fibrosis, and serum markers of fibrosis in a multi-center clinical trial in nonalcoholic steatohepatitis (NASH) (2017) (7)
Improved Assessment of Hepatic Steatosis in Humans Using Multi-Parametric Quantitative Ultrasound (2019) (7)
How to Use LI-RADS to Report Liver CT and MRI Observations. (2021) (6)
Surveillance of hepatocellular carcinoma by medical imaging. (2019) (6)
Measurement of spleen fat on MRI-proton density fat fraction arises from reconstruction of noise (2019) (6)
Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis (2018) (6)
Liver-tumor detection with ultrasound contrast: a blinded prospective study in rabbits. (1998) (6)
The relationship between liver triglyceride composition and proton density fat fraction as assessed by 1H MRS (2020) (6)
Delayed traumatic bladder rupture. (2005) (6)
Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver disease (2017) (6)
Disorders of Iron Overload (2015) (6)
Effect of Fat Spectral Model Parameters on Hepatic Fat Quantification by Multi-Echo Gradient-Echo Magnetic Resonance Imaging (2009) (6)
Quantitative magnetic resonance imaging for chronic liver disease. (2021) (6)
Increasing the sensitivity of LI-RADS v2018 for diagnosis of small (10–19 mm) HCC on extracellular contrast-enhanced MRI (2020) (6)
Fully automated convolutional neural network-based affine algorithm improves liver registration and lesion co-localization on hepatobiliary phase T1-weighted MR images (2019) (6)
Effects of T1, T2, and Spectral Complexity on In- and Out-of-Phase Imaging: A systematic approach by computer simulation (2007) (6)
Imaging Diagnosis of Hepatocellular Carcinoma: The Liver Imaging Reporting and Data System, Why and How? (2020) (6)
Two-step strategy, FIB-4 followed by magnetic resonance elastography, for detecting advanced fibrosis in NAFLD. (2022) (5)
Abbreviated Magnetic Resonance Imaging for HCC Surveillance (2021) (5)
Nonalcoholic Fatty Liver Disease: Diagnostic and Fat-Grading AccuracyofLow-Flip-AngleMultiecho Gradient-Recalled-EchoMRImaging (2009) (5)
Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis (2021) (5)
Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma (2021) (5)
Callback and follow-up guidelines for whole-body CT screening. (2006) (5)
Convolutional neural network-automated hepatobiliary phase adequacy evaluation may optimize examination time. (2020) (5)
Pseudo-tetrahedral semi-sandwich cycloruthenated compounds: 1H NMR data and DFT-calculations about the racemisation process of the ruthenium atom (2002) (5)
Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease. (2022) (4)
MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T (2021) (4)
Evaluation of Quantitative Imaging Biomarkers for Early Phase Clinical Trials of Steatohepatitis in Adolescents. (2019) (4)
A new liver explant fixation technique. (2009) (4)
Vascular Contact With Soft Tissue: A Sign of Mesenteric Masses at Computed Tomography (2008) (4)
Validation of Chemical Shift Based Fat-Fraction Imaging with MR Spectroscopy (2009) (4)
Temperature‐corrected proton density fat fraction estimation using chemical shift‐encoded MRI in phantoms (2021) (4)
Solvent and Dynamic Effects on the Structure of Alkali Cation Complexes of the t-Butyl-calix[4]arene Anion: MD and FEP Computer Investigations on the Na+/Cs+ Binding Affinity (1996) (4)
Title Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI : The atlas Permalink (2012) (4)
Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients (2017) (4)
Imaging Features at the Periphery: Hemodynamics, Pathophysiology, and Effect on LI-RADS Categorization. (2021) (4)
Use of the Liver Imaging Reporting and Data System in Hepatocellular Carcinoma. (2017) (4)
Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD. (2022) (4)
Editorial for "Interreader Agreement of Liver Imaging Reporting and Data System on MRI: A Systematic Review and Meta Analysis". (2020) (4)
Preliminary efficacy and safety of acetyl-CoA carboxylase inhibitor GS-0976 in patients with compensated cirrhosis due to NASH (2018) (3)
Image Annotation by Eye Tracking: Accuracy and Precision of Centerlines of Obstructed Small-Bowel Segments Placed Using Eye Trackers (2019) (3)
Hepatic Steatosis is Negatively Associated with Bone Mineral Density in Children. (2021) (3)
Automated CNN-Based Analysis Versus Manual Analysis for MR Elastography in Nonalcoholic Fatty Liver Disease: Inter-method Agreement and Fibrosis Stage Discriminative Performance. (2022) (3)
Transient homogeneously enhancing hepatic masses: can size predict benignity? (2008) (3)
The Dose-Response Effects of Consuming High Fructose Corn Syrup-Sweetened Beverages on Hepatic Lipid Content and Insulin Sensitivity in Young Adults (2022) (3)
Assessing liver fat fraction by ARFI induced shear wave attenuation: A preliminary result (2013) (3)
Fatty Liver Disease (2011) (3)
Effect of ultrasound transmit power on liver enhancement with Imagent® US, a PFC-stabilized microbubble contrast agent (1997) (3)
Synthesis, Characterization, and Fluxional Behavior of a 34 Electron Homochiral Dimetallic Complex with an Unsupported Hydride Bridge between Two Ru Atoms (2012) (3)
Contrast Enhanced Ultrasound: Liver Imaging Reporting and Data System (CEUS LI-RADS) (2017) (3)
Diarylmethyl Ethers and Pd Salts or Complexes: A Perfect Combination for the Protection and Deprotection of Alcohols. (2009) (3)
Imaging techniques for hepatocellular carcinoma. (2015) (3)
Mo1009 Magnetic Resonance Elastography Accurately Predicts Advanced Fibrosis in NAFLD: A Pilot Study With Paired-Liver Biopsy (2013) (3)
Imaging of hepatocellular carcinoma: a pilot international survey (2020) (3)
Repeatability and accuracy of various region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification (2021) (3)
Liver Imaging Reporting and Data System Comprehensive Guide: MR Imaging Edition. (2021) (3)
Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine (2021) (3)
Imaging Techniques for the Assessment of Ectopic Fat in Liver and Skeletal Muscle (2015) (3)
The Vascular Space (1999) (3)
Evaluation of the ability of an organic derivative of ruthenium(II) to reinforce the cytotoxicity of fast neutron against malignant cells in culture (2008) (2)
Ovarian imaging by magnetic resonance in obese adolescent females with polycystic ovary syndrome (PCOS) (2004) (2)
Blunt Abdominal Trauma: Screening US in 2,693 (2001) (2)
Technical report: gadoxetate-disodium-enhanced 2D R2* mapping: a novel approach for assessing bile ducts in living donors (2018) (2)
Quantitative liver fat fraction measurement by multi-view sonography using deep learning and attention maps (2019) (2)
Percentages of Hepatocellular Carcinoma in LI-RADS Categories with CT and MRI: A Systematic Review and Meta-Analysis. (2023) (2)
GASTROINTESTINAL IMAGING : Imaging Outcomes of Liver Imaging Reporting and Data System Observations (2016) (2)
949 Sitagliptin Versus Placebo in the Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (2016) (2)
LI-RADS: Looking Back, Looking Forward. (2023) (2)
Treatment with selonsertib, an inhibitor of apoptosis signal-regulating kinase 1, hepatic phospho-p38 expression and markers of hepatocellular apoptosis and necrosis in patients with nonalcoholic steatohepatitis (2017) (2)
Scientific Paper Abstracts Presented at the Society of Abdominal Radiology 2017 Annual Scientific Meeting and Educational Course (March 26–31, 2017, Hollywood, Florida) (2017) (2)
Imaging of NAFLD (2013) (2)
PdCl2, a Useful Catalyst for Protection of Alcohols as Diphenylmethyl (DPM) Ethers. (2008) (2)
LI‐RADS: Future Directions (2021) (2)
Scientific Paper Abstracts Presented at the Society of Abdominal Radiology 2016 Annual Scientific Meeting and Educational Course March 13–18, 2016, Waikoloa, Hawaii (2016) (2)
CT evaluation of gastrointestinal tumors: Imaging techniques and key diagnostic findings (2005) (2)
Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C) (2020) (2)
Enantioselective recognition of chiral carboxylic anions by a ruthenacyclic receptor (2010) (2)
Su1521 - Preliminary Efficacy and Safety of Acetyl-Coa Carboxylase (ACC) Inhibitor GS-0976 in Patents with Compensated Cirrhosis due to NASH (2018) (1)
CNN color-coded difference maps accurately display longitudinal changes in liver MRI-PDFF (2021) (1)
Universal Liver Imaging Lexicon: Imaging Atlas for Research and Clinical Practice. (2023) (1)
What proportion of LI-RADS 5 observations reported in clinical practice do not meet LI-RADS 5 criteria? (2021) (1)
Universal Liver Imaging Lexicon: Imaging Atlas for Research and Clinical Practice. (2023) (1)
905 Non-Invasive Screening for NAFLD and Advanced Fibrosis in Diabetics in Primary Care Setting by MRI and MRE: A Prospective Pilot Study (2015) (1)
Repeatability and accuracy of a novel, MRI-based, semi-automated analysis method for quantifying abdominal adipose tissue and thigh muscle volumes (2016) (1)
Changes in abdominal adipose tissue depots accessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis. (2022) (1)
LI-RADS v2018: a Primer and Update for Clinicians (2018) (1)
Imaging the obstructed bowel and other intestinal emergencies (2005) (1)
Multiinstitutional Evaluation of the Liver Surface Nodularity Score on CT for Staging Liver Fibrosis and Predicting Liver-Related Events in Patients with Hepatitis C. (2021) (1)
The Dissemination of Hepatocellular Carcinoma Diagnosis Guidelines Using the Method of Teaching the Teachers. (2020) (1)
Point‐of‐care magnetic resonance technology to measure liver fat: Phantom and first‐in‐human pilot study (2022) (1)
Hepatic Proton Density Fat Fraction Correlates with Histologic Measures of Steatosis and is Responsive to Change in those Measures in a Multi-Center Nonalcoholic Steatohepatitis Clinical Trial (2017) (1)
PS-186-Functional liver imaging score derived from gadoxetic acid-enhanced MRI predicts outcomes in patients with advanced chronic liver disease (2019) (1)
Hepatic Iron Overload (2011) (1)
Erratum to: Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid (2017) (1)
Gadolinium-DTPA-dextran: A molecular MR blood pool contrast agent (2005) (1)
Blood vessel effects in quantitative ultrasound attenuation and backscatter (2019) (1)
Magnetic Resonance Elastography versus Transient Elastography in detection of fibrosis in nonalcoholic fatty liver disease: A systematic review and meta-analysis of individual participant date (2018) (1)
Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma (2021) (1)
EXHIBIT 703 Disproportionate Fat Stranding : A Helpful CT Sign in Patients with Acute Abdominal Pain 1 LEARNING (2004) (1)
Complex and Magnitude MRI for Quantification of Hepatic Steatosis – Correlation with MR Spectroscopy and Biopsy (2012) (1)
Bias , and Precision of hepatic Proton Density Fat Fraction Measurements by Using Mr imaging : A Meta-Analysis 1 (2018) (1)
1908-P: Factors Related to Hepatic Fat and Fibrosis in American Indians (2019) (1)
Organ Procurement and Transplantation Network HCC Classification: Alignment with LI-RADS, Current Gaps, and Future Direction. (2022) (1)
Steatosis, Steatohepatitis, Nonalcoholic Fatty Liver Disease, and Nonalcoholic Steatohepatitis (2015) (1)
Cross-sectional Imaging of Extranodal Involve- ment in Abdomino- pelvic Lymphoprolif- (2007) (1)
Examining LI-RADS recommendations: should observation size only be measured on non-arterial phases? (2020) (1)
CT and MR Imaging of Extrahepatic Fatty Masses of the Abdomen and Pelvis: Techniques, Diagnosis, Differential (2005) (1)
SUPRAMOLECULAR CATALYSIS BY CYCLODEXTRINS AND MACROCYCLIC POLYETHERS. (A REVIEW) (1984) (1)
CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Heritability of Nonalcoholic Fatty Liver Disease (2009) (1)
Tu1027 Effect of Colesevelam on Magnetic Resonance Imaging Derived Fat Maps in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial (2012) (1)
Intrahepatic Fat, Not Obesity, Is a Main Driver of the Metabolic Syndrome in Obese Patients and Is Significantly Reduced by Weight Loss Surgery (2016) (1)
Responsiveness of controlled attenuation parameter (CAP) and its correlation with magnetic resonance imaging-proton density fat fraction (MRI-PDFF) in a multi-center clinical trial of subjects with nonalcoholic steatohepatitis (NASH) (2018) (0)
Automated Registration of Sequential Breath-Hold DCE-MRI Images (2008) (0)
Su1532 - Effect on Accuracy of a Quantitative Imaging Assessment Biomarker Metric for Mri-Estimated Proton Density Fat Fraction (2018) (0)
Left-right bias in triglyceride composition of adipose tissue measured by 1 H MRS (2012) (0)
Synthesis of a chiral asymmetrical NCN ligand and its metallation (2009) (0)
Comparison of quantitative ultrasound parameters from two approaches on in vivo human fatty liver (2016) (0)
LI-RADS : Review of Major Imaging Features (2016) (0)
Chapter 15 – Imaging and Noninvasive Diagnosis of Liver Disease: Computerized Tomography, Ultrasound, Magnetic Resonance Imaging, and Emerging Techniques (2012) (0)
Validation of a quantitative imaging assessment biomarker metric for MRI-estimated proton density fat fraction in a large multi-center clinical trial (2018) (0)
LINICAL ADVANCES IN LIVER , PANCREAS , ND BILIARY TRACT eritability of Nonalcoholic Fatty Liver Disease (0)
Histogram analysis of hepatocellular phase MR imaging as a quantitative value for hepatic fibrosis: preliminary observations (2012) (0)
Liver Fat Droplet Dependency on Ultrasound Backscatter Coefficient in Nonalcoholic Fatty Liver (2020) (0)
The Use of Heavily T 1-Weighted Sequences for Fat Quantification (2008) (0)
Hepatic Veno-occlusive Diseases (2011) (0)
A doubly hermaphroditic chiral crown ether (2014) (0)
Gut Microbiome-Based Me tagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease Graphical Abstract Highlights d Gut microbiota is associated with advanced fibrosis in human NAFLD d Metagenome-based gut microbiome panel can accurately diagnose (2017) (0)
Cholestatic Hepatic Disorders (2011) (0)
Portal Vein Disorders (2015) (0)
Veno-Occlusive Disorders (2015) (0)
Accuracy of magnitude- and complex-reconstruction chemical-shift-encoded magnetic resonance imaging proton density fat fraction for diagnosis of hepatic steatosis in subjects with severe obesity using histology as reference (2018) (0)
Hepatic Storage Disorders (2011) (0)
Quantiﬁ cation of Hepatic Steatosis with T1-independent, T2*-corrected MR Imaging with Spectral Modeling of Fat : Blinded Comparison with MR Spectroscopy 1 (2011) (0)
Deep learning approaches for quantitative analysis of ultrasound backscattered signals (2019) (0)
Inter-sonographer reproducibility of ultrasonic attenuation backscatter coefficient measures in adults with nonalcoholic fatty liver disease (2018) (0)
Letter to the editor response (2005) (0)
Mo1005 Effect of Weight Loss on Novel MRI Quantitative Changes in Liver and Pancreatic Fat in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease (2013) (0)
745 UTILITY OF MAGNETIC RESONANCE ELASTOGRAPHY IN ACCURATE DETECTION OF CANDIDATES FOR PHARMACOLOGIC TREATMENT OF NASH-RELATED FIBROSIS: A PROSPECTIVE COHORT STUDY (2020) (0)
Association of Hepatic Steatosis with Adipose and Muscle Mass and Distribution in Children. (2023) (0)
Even modest alcohol use is associated with greater steatosis on magnetic resonance imaging in patients with NAFLD – a pilot study (2018) (0)
Su1594 GUT MICROBIOME METAGENOMICS REVEALS FUNGAL MYCOBIOME ALTERATION IN NAFLD CIRRHOSIS WITH VALIDATION IN A GEOGRAPHICALLY INDEPENDENT COHORT (2020) (0)
Imaging Non-alcoholic Fatty Liver Disease Model Using H-1 and F-19 MRI. (2022) (0)
Cystic Hepatic Tumors (2015) (0)
Hepatocellular Carcinoma: It Is Time to Focus on Prognosis. (2023) (0)
O020 : Magnetic resonance elastography is superior to clinical prediction models for determination of advanced fibrosis in patients with non-alcoholic fatty liver disease: A prospective study (2015) (0)
Benign Liver Tumors (2015) (0)
Erratum to: Point‐of‐care magnetic resonance technology to measure liver fat: Phantom and first‐in‐human pilot study (Magn Reson Med. 2022;88:1794‐1805) (2022) (0)
A safety, feasibility and accuracy study of laparoscopic computer-assisted navigated microwave ablation of liver tumors Diagnostic Accuracy and Reliability of Supersonic Shear Imaging in Comparison with Transient Elastography for Assessment of Liver Fibrosis in Patients with Chronic Liver Disease (2014) (0)
Monte Carlo modeling of hepatic steatosis based on stereology and spatial distribution of fat droplets (2023) (0)
Secondary Liver Tumors (2015) (0)
CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis. (2023) (0)
Transjugular Intrahepatic Portosystemic Shunt Complicated by Biliary Fistula and Intrahepatic Biliary Obstruction: 488 (2005) (0)
Normal Anatomy and Imaging Techniques of the Liver (2015) (0)
Identifying nonalcoholic fatty liver disease from quantitative ultrasound measures (2018) (0)
Other Metabolic Disorders (2015) (0)
Non-invasive Quantitative Magnetic Resonance Imaging and Spectroscopic Biomarkers in Nonalcoholic Fatty Liver Disease and Other Cardiometabolic Diseases Associated with Ectopic Fat Deposition (2019) (0)
Assessment of hepatic steatosis in humans using multivariable quantitative ultrasound (2019) (0)
Invited commentary. (2012) (0)
Uncommon Solid Liver Tumors (2015) (0)
Invited commentary. (2009) (0)
O80 NOVEL 3-DIMENSIONAL MAGNETIC RESONANCE ELASTOGRAPHY ACCURATELY DIAGNOSES NASH AND ADVANCED FIBROSIS IN PATIENTS WITH BIOPSY-PROVEN NAFLD: A PROSPECTIVE COHORT STUDY (2014) (0)
PS-157-Gut microbiome signature for cirrhosis due to non-alcoholoic fatty liver disease: A prospective twin and family study (2019) (0)
1097 The Intestinal Microbiome in Children With Nonalcoholic Fatty Liver Disease–A Case-Control Study (2016) (0)
RepeatabilityandReproducibilityof the UltrasonicAttenuationCoefficient and BackscatterCoefficientMeasured in the Right Lobeof theLiver inAdultsWith KnownorSuspectedNonalcoholicFatty LiverDisease (2018) (0)
Mo1542 Effect of Weight Loss on MRE Estimated Stiffness in Patients With Nonalcoholic Fatty Liver Disease (2016) (0)
MR Imaging of Chronic Liver Diseases and Liver Cancer. (2021) (0)
Double contrast (DC) enhanced magnetic resonance imaging (MRI) of the liver: Where do we stand today? (2009) (0)
Patient Specific Biomechanics Are Clinically Significant In Accurate Computer Aided Surgical Image Guidance (2020) (0)
Editorial for “A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid‐Enhanced MRI Features” (2021) (0)
Palladium‐Catalyzed Synthesis of Dibenzo[de,g]quinolines. A Novel Approach to the B‐Ring System of Aporphine‐Related Heterocycles. (1999) (0)
, MD application of Modified spin-echo – based sequences for hepatic Mr elastography : Evaluation , Comparison with the Conventional Gradient-Echo Sequence , and Preliminary Clinical Experience 1 (2017) (0)
CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part I. Development, Growth, and Spread: Key Pathologic and Imaging Aspects 1 (2014) (0)
MR Imaging of Chronic Liver Diseases and Liver Cancer (2021) (0)
Hepatocellular Carcinoma and Precursors (2015) (0)
Palladium-Assisted Intramolecular Formation of N-Heterocycles by sp2 N Nucleophilic Attack on η3-allyl-Pd Complexes Generated by Allene Insertion into σ Pd-C Bond. (1997) (0)
Imaging Biomarkers for Diagnosis of Nonalcoholic Steatohepatitis (NASH) (2020) (0)
Repeatability and reproducibility of ultrasonic attenuation coefficient and backscatter coefficient measures in adults with non-alcoholic fatty liver disease (2016) (0)
Feasibility of an automated tissue segmentation technique in a longitudinal weight loss study (2016) (0)
A New Liver Explant Fixation Technique. Authors' reply (2008) (0)
Sa1046 Differential Effects of Very Low Calorie Diet on Body Weight, Liver Fat and Liver Volume in Obese Adults Prior to Weight Loss Surgery (2014) (0)
Development and blinded test of a software tool for ultrasound-based hepatic fat fraction estimation (2019) (0)
Study of ultrasonic scattering mechanisms in nonalcoholic fatty liver disease using liver histopathological slides (2020) (0)
WE-EF-210-05: Diagnosis and Quantification of Liver Steatosis with Quantitative Ultrasound Backscatter Technique (2015) (0)
Estimating liver fat fraction from ultrasonic attenuation and backscatter coefficient measures in adults with nonalcoholic fatty liver disease (2018) (0)
355 - Higher Quantity of Liver Fat Content is Associated with the Development of Early Fibrosis in NAFLD: A Prospective Longitudinal Study (2018) (0)
Same Day 1.5T vs 3T Reproducibility of Liver Proton Density Fat Fractions in Obese Patients (2014) (0)
nonalcoholic Fatty liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis 1 (2013) (0)
Reproducibility of MRI-Determined Proton Density Fat Fraction (PDFF) across MR Scanner Platforms and Field Strength (2010) (0)
WITHDRAWN: Diagnostic Performance of LI-RADS for MRI and CT Detection of HCC: A Systematic Review and Diagnostic Meta-analysis (2020) (0)
Tu1028 Correlation Between Liver Histology and Novel Magnetic Resonance Imaging in Adult Patients With Nonalcoholic Fatty Liver Disease (2012) (0)
O040 : Heritability of hepatic fibrosis and hepatic steatosis, and their shared gene effects with metabolic traits in NAFLD: A prospective twin study (2015) (0)
accuracy of M r imaging- estimated Proton Density Fat Fraction for classification of Dichotomized histologic s teatosis grades in nonalcoholic (2015) (0)
The Organ Procurement and Transplantation Network hepatocellular carcinoma classification: Alignment with Liver Imaging Reporting and Data System, current gaps, and future direction (2023) (0)
Tu1706 Magnetic Resonance Elastography Identifies Fibrosis in Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Pilot Prospective Study (2016) (0)
Su1541 - Responsiveness of Controlled Attenuation Parameter (CAP) and Its Correlation with Magnetic Resonance Imagingproton Density Fat Fraction (MRI-PDFF) in a Multi-Center Clinical Trial of Subjects with Nonacoholic Steatohepatitis (NASH) (2018) (0)
Interpretability and generalizability of a one-dimensional convolutional neural network method for hepatic steatosis characterization (2019) (0)
464 Novel Cardiovascular Risk Assessment in the Treatment of Nonalcoholic Steatohepatitis: Secondary Analysis of the MOZART Randomized Clinical Trial (2015) (0)
Shared Gene Effects between Hepatic Steatosis and Fibrosis: A Prospective Twin Study (2016) (0)
277 Heritability of Hepatic Fibrosis and Hepatic Steatosis, and Their Shared Gene Effects With Metabolic Traits in NAFLD: A Prospective Twin Study (2015) (0)
Ex-vivo MR imaging of excised human livers as a new method to reliably co-localize nodules and nodule components on imaging and pathology: preliminary 6-month experience (2009) (0)
LBP-14-Magnetic Resonance Biomarkers for Early Phase Steatohepatitis Clinical Trials: Short Term Evaluation in Adolescents, Transitoriness or Stability in Steatosis (STEATOSIS) (2019) (0)
MRI Quantification of Placebo Effect in Nonalcoholic Steatohepatitis Clinical Trials. (2022) (0)
Imaging Techniques for Hepatocellular Carcinoma. (2015) (0)
Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI. (2014) (0)
Does Attenuation of Perfusion in Diffusion Weighted-MRI Behave as Exponential Decay or as Damped Oscillation ? (2011) (0)
947 Shared Genetic Effects Between Hepatic Steatosis and Fibrosis: A Prospective Twin Study (2016) (0)
imaging Outcomes of liver imaging r eporting and Data s ystem Version 2014 category 2 (2016) (0)
Paper alert (2016) (0)
Sa1001 Magnetic Resonance Elastography Is Superior to Clinical Prediction Models for Determination of Advanced Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease: A Prospective Study (2015) (0)
Mo1449 OPTIMAL NON-INVASIVE SCREENING STRATEGY FOR NONALCOHOLIC FATTY LIVER DISEASE IN A PROSPECTIVE COHORT OF PATIENTS WITH TYPE 2 DIABETES (2020) (0)
The Dark Side of the Liver: The Atypical Malignancies in Cirrhosis (2020) (0)
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease (2019) (0)
CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT SAFETY Study: Alanine Aminotransferase Cutoff Values Are Set Too High for Reliable Detection of Pediatric Chronic Liver Disease (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Claude B. Sirlin?

Claude B. Sirlin is affiliated with the following schools:

University of Strasbourg
University of California, San Diego
Stanford University